Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06924944 · ClinicalTrials.gov registry record
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
A clinical trial of Cataract Surgery and Correction Vision Surgery, sponsored by Utah Eye Centers.
- Recruiting
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT06924944: Recruiting study of Cataract Surgery and Correction Vision Surgery, sponsored by Utah Eye Centers.
NCT06924944 is a study of Cataract Surgery and Correction Vision Surgery that is actively recruiting participants, run by Utah Eye Centers. The registered enrollment target is 35 participants, below the 141-participant average among 7 other Cataract Surgery trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06924944, a study of Cataract Surgery and Correction Vision Surgery, is actively recruiting participants, sponsored by Utah Eye Centers.
- RECRUITING
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on nearby objects)and cataract. However, having a history of refractive surgery, poses challenges in the selection of the IOLs and can lead to visual outcomes that are unpredictable. Data from an international registry and single prospective study show that Vivity IOL provided effective distance, intermediate and near vision in eyes with previous LASIK with minimal effects on day vision associated with the surgery. The purpose of this study is to evaluate the clinical outcomes of post-myopic refractive surgery patients implanted with the Clareon Vivity/Vivity Toric lenses
Conditions Studied
Interventions
- PROCEDURE cataract surgery
Study Locations (1)
Utah
- Utah Eye Centers - Ogden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2026-04 |
What NCT06924944 shows while recruiting
NCT06924944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 141-participant average among 7 other Cataract Surgery trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Cataract Surgery appearing as the primary indexed condition, and to 1 intervention - of which cataract surgery is the first listed.
NCT06924944 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06924944 about?
NCT06924944 is a clinical study titled "Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients". Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on nearby objects)and cataract. However, having a history of refractive surgery, poses challenges in the...
What is the current status of trial NCT06924944?
This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2025-01-20. Estimated completion is 2026-04.
What conditions does trial NCT06924944 study?
This clinical trial studies the following conditions: Cataract Surgery, Correction Vision Surgery.
What interventions are being tested in trial NCT06924944?
The interventions under investigation include: cataract surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06924944?
This trial is sponsored by Utah Eye Centers, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06924944 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Remimazolam for Cataract Surgery
RECRUITING · Phase 4
-
Efficacy and Safety of Bromfenac Ophthalmic Solution
COMPLETED · Phase 2
-
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
COMPLETED · NA
-
Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI